Therapeutic and genetic prospects of an atypical affective disorder

J Raymond Depaulo, Sylvia G. Simpson

Research output: Contribution to journalArticle

Abstract

The utility of bipolar type II affective disorder subgrouping is discussed. There is low diagnostic agreement among clinicians for this putative condition. However, the clustering of cases in families and the poor response to standard treatments sug-gest that it is a distinct subgroup. The clinical features of the depressive phase of this condition including chronicity, intermittency, hyperphagia, hypersomnia, and reactivity relate it to the con-structs of “hysteroid dysphoria,” atypical depression, and seasonal affective disorder. Its association to several abnormal motivated behaviors such as alcoholism and eating disorders allows the speculation that a distinct morbid mechanism involving serotonin may underlie it and that new serotonin reuptake blocking drugs may be useful in treating it. Finally, the genetic identity of this subgroup in all likelihood will be established or rejected by genetic linkage studies utilizing the restriction fragment length polymorphism map of the genome.

Original languageEnglish (US)
Pages (from-to)50S-54S
JournalJournal of Clinical Psychopharmacology
Volume7
Issue number6
StatePublished - 1987

Fingerprint

Mood Disorders
Serotonin
Seasonal Affective Disorder
Disorders of Excessive Somnolence
Hyperphagia
Genetic Linkage
Pedigree
Restriction Fragment Length Polymorphisms
Alcoholism
Cluster Analysis
Genome
Depression
Therapeutics
Pharmaceutical Preparations
Feeding and Eating Disorders

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Psychiatry and Mental health
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Therapeutic and genetic prospects of an atypical affective disorder. / Depaulo, J Raymond; Simpson, Sylvia G.

In: Journal of Clinical Psychopharmacology, Vol. 7, No. 6, 1987, p. 50S-54S.

Research output: Contribution to journalArticle

@article{0999612d61174df48b3f9ecd2060cfbc,
title = "Therapeutic and genetic prospects of an atypical affective disorder",
abstract = "The utility of bipolar type II affective disorder subgrouping is discussed. There is low diagnostic agreement among clinicians for this putative condition. However, the clustering of cases in families and the poor response to standard treatments sug-gest that it is a distinct subgroup. The clinical features of the depressive phase of this condition including chronicity, intermittency, hyperphagia, hypersomnia, and reactivity relate it to the con-structs of “hysteroid dysphoria,” atypical depression, and seasonal affective disorder. Its association to several abnormal motivated behaviors such as alcoholism and eating disorders allows the speculation that a distinct morbid mechanism involving serotonin may underlie it and that new serotonin reuptake blocking drugs may be useful in treating it. Finally, the genetic identity of this subgroup in all likelihood will be established or rejected by genetic linkage studies utilizing the restriction fragment length polymorphism map of the genome.",
author = "Depaulo, {J Raymond} and Simpson, {Sylvia G.}",
year = "1987",
language = "English (US)",
volume = "7",
pages = "50S--54S",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Therapeutic and genetic prospects of an atypical affective disorder

AU - Depaulo, J Raymond

AU - Simpson, Sylvia G.

PY - 1987

Y1 - 1987

N2 - The utility of bipolar type II affective disorder subgrouping is discussed. There is low diagnostic agreement among clinicians for this putative condition. However, the clustering of cases in families and the poor response to standard treatments sug-gest that it is a distinct subgroup. The clinical features of the depressive phase of this condition including chronicity, intermittency, hyperphagia, hypersomnia, and reactivity relate it to the con-structs of “hysteroid dysphoria,” atypical depression, and seasonal affective disorder. Its association to several abnormal motivated behaviors such as alcoholism and eating disorders allows the speculation that a distinct morbid mechanism involving serotonin may underlie it and that new serotonin reuptake blocking drugs may be useful in treating it. Finally, the genetic identity of this subgroup in all likelihood will be established or rejected by genetic linkage studies utilizing the restriction fragment length polymorphism map of the genome.

AB - The utility of bipolar type II affective disorder subgrouping is discussed. There is low diagnostic agreement among clinicians for this putative condition. However, the clustering of cases in families and the poor response to standard treatments sug-gest that it is a distinct subgroup. The clinical features of the depressive phase of this condition including chronicity, intermittency, hyperphagia, hypersomnia, and reactivity relate it to the con-structs of “hysteroid dysphoria,” atypical depression, and seasonal affective disorder. Its association to several abnormal motivated behaviors such as alcoholism and eating disorders allows the speculation that a distinct morbid mechanism involving serotonin may underlie it and that new serotonin reuptake blocking drugs may be useful in treating it. Finally, the genetic identity of this subgroup in all likelihood will be established or rejected by genetic linkage studies utilizing the restriction fragment length polymorphism map of the genome.

UR - http://www.scopus.com/inward/record.url?scp=0023583011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023583011&partnerID=8YFLogxK

M3 - Article

C2 - 3323266

AN - SCOPUS:0023583011

VL - 7

SP - 50S-54S

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 6

ER -